Foundation Models for Cardiovascular Disease and Medicine

Clicks: 9
ID: 321281
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #44 of 64 articles by views in European Heart Journal - Digital Health

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Cardiovascular disease (CVD) remains the leading cause of mortality worldwide, accounting for more than 17 million deaths annually. Foundation models (FMs) are large-scale artificial intelligence systems pre-trained on broad datasets and increasingly studied for cardiovascular diagnosis, risk prediction, workflow support, and treatment personalization. Methods This narrative review synthesized FMs applied to cardiovascular medicine, including text-based, image-based, multimodal, and time-series models. The review examined model architectures, training strategies, performance metrics, clinical applications, implementation challenges, and evidence maturity using a three-tier framework. Results Cardiovascular FMs show promising but unevenly validated capabilities across multiple applications. ECG-based models such as ECGFounder have reported strong external validation performance for rhythm and conduction diagnoses, whereas imaging models such as Echo-Vision-FM supports cardiac function assessment and pathology classification. Multimodal models, including CardioGPT and EchoCLIP, illustrate the potential value of integrating clinical text, imaging, and physiological signals, although several remain at a conceptual or proof-of-concept stage. Conclusions FMs may become important tools in cardiovascular medicine by supporting earlier diagnosis, risk stratification, and clinical decision-making. However, the current evidence base remains heterogeneous, and major barriers persist, including limited interpretability, underrepresentation of diverse populations in training data, regulatory uncertainty, computational demands, and workflow-integration challenges. Inclusive data development, transparent reporting, external validation, prospective clinical evaluation, and interdisciplinary implementation research are needed before these models can be deployed safely and equitably in routine cardiovascular care.
Reference Key
openalex_W7169123637 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors J J Ye, Sophie Bronstein, Malak Abu Hashish
Journal European Heart Journal - Digital Health
Year 2026
DOI
10.1093/ehjdh/ztag113
URL
https://doi.org/10.1093/ehjdh/ztag113
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.